| Christine Charest, LMFT | |
|
1155 Lisbon St, Lewiston, ME 04240-5025 | |
| (207) 783-9141 | |
| Not Available |
| Full Name | Christine Charest |
|---|---|
| Gender | Female |
| Speciality | Marriage & Family Therapist |
| Location | 1155 Lisbon St, Lewiston, Maine |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699867267 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | MF3189 (Maine) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Christine Charest, LMFT 87 Pond Rd, Lewiston, ME 04240-1608 Ph: () - | Christine Charest, LMFT 1155 Lisbon St, Lewiston, ME 04240-5025 Ph: (207) 783-9141 |
News Archive
Inhibikase Therapeutics, Inc. announces the launch of an observational clinical study in patients who contracted Progressive Multifocal Leukoencephalopathy (PML), the rare and often fatal brain infection that arises as an unintended side effect of some medications used for treatment of Multiple Sclerosis, Crohn's disease, Ulcerative Colitis and certain cancers of the blood and lymph.
Researchers at Center for BrainHealth, part of The University of Texas at Dallas, collaborated with scientists at the University of North Carolina at Chapel Hill to examine whether the Strategic Memory Advanced Reasoning Training (SMART) program affects people's abilities to make informed decisions about their medical treatment options.
Sapiens Steering Brain Stimulation B.V. (Sapiens), an emerging medical technology company developing brain stimulation products, today announced that it has raised €7.5 m from the Dutch investment group INKEF Capital, in a further extension of their Series A financing round. The proceeds will be used for the development of its Steering Brain Stimulation implant and procedure solutions to treat Parkinson's disease (PD) and other functional brain disorders.
The results of a long-term clinical trial on a new drug designed to inhibit the progression of type I diabetes was announced at the International Diabetes Society meeting in Cambridge, England, March 29. The findings of the 18-month long clinical trial confirm the drug's efficacy in improving a diabetic's ability to produce insulin.
Stem cells culled from bone marrow may prove beneficial in stroke recovery, scientists at UC Irvine's Sue & Bill Gross Stem Cell Research Center have learned.
› Verified 3 days ago
Patricia Proulx-lough, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 1155 Lisbon St, Lewiston, ME 04240 Phone: 207-783-9141 |